Destiny Pharma Ltd Company Profile

19:51 EST 13th December 2018 | BioPortfolio

Destiny Pharma is a UK based anti-infectives pharmaceutical company founded, in 1997, by pharma industry executives. The company has developed and patented a portfolio of novel drugs that have a completely different mode of action from conventional antibiotics. These compounds (codenamed XF Drugs) have been shown to work in such a way that minimizes the development of bacterial resistance to repeated dosing. Our compounds can therefore be used to prevent and treat “superbugs” such as methicillin-resistant Staphylococcus aureus (MRSA); one of the major unmet needs of western medicine.


at the Sussex Innovation Centre Science Park Square, Falmer
United Kingdom


Phone: 44 (0) 1273 704 440
Fax: 44 (0) 1273 704 499

News Articles [519 Associated News Articles listed on BioPortfolio]

Destiny Pharma (DEST) - Destiny beguiles

Edison Investment Research - Pharmaceutical & healthcare - Destiny Pharma: Destiny Pharma is a virtual antimicrobial discovery company in Phase II clinical studies in the US. Destiny’s XF series...

Destiny Pharma (DEST) - Porphyrins ring time on antibiotic resistance

Edison Investment Research - Pharmaceutical & healthcare - Destiny Pharma: Destiny Pharma’s H118 financial results were less about the numbers and more about the preparation for XF-73’s US...

Destiny Pharma’s XF-73 succeeds in phase 1 skin irritation study

Destiny Pharma, a UK-based clinical stage biotechnology company, has reported positive data for its synthetic antimicrobial drug XF-73 from a phase 1 skin irritation study.

Destiny Pharma's XF-73 Being Studied For Diabetic Foot Ulcers, Burns Too

One year after its IPO, UK-based Destiny Pharma's CEO tells Scrip it's on track with US development of its lead...   

Pharma industry appointments

Destiny Pharma, Silence Therapeutics and Concept Life Sciences add to its teams.

Destiny Pharma names new chairman

Nick Rodgers joins Destiny Pharma

Destiny Pharma appoints Nick Rodgers as non-executive director

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

Clinical Trials [89 Associated Clinical Trials listed on BioPortfolio]

Diafert for Embryo Selection and Fertility Improvement (DESTINy)

Prospective, single-center, single-blind, randomized, controlled, two-arm, interventional study.

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Companies [783 Associated Companies listed on BioPortfolio]

Destiny Pharma Ltd

Destiny Pharma is a UK based anti-infectives pharmaceutical company founded, in 1997, by pharma industry executives. The company has developed and patented a portfolio of novel drugs that have a compl...

Destiny Pharma

Destiny Pharma offers a custom research service where tailor made research studies are constructed and performed to the specific requirements of each client.Destiny Pharma specialise in:- Formulation ...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

More Information about "Destiny Pharma Ltd" on BioPortfolio

We have published hundreds of Destiny Pharma Ltd news stories on BioPortfolio along with dozens of Destiny Pharma Ltd Clinical Trials and PubMed Articles about Destiny Pharma Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Destiny Pharma Ltd Companies in our database. You can also find out about relevant Destiny Pharma Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Corporate Database Quicklinks

Searches Linking to this Company Record